Gene Namea | Gene function | Fold change | Reference |
---|---|---|---|
ENPP7+ | Might have an inflammatory effect, as it could degrade and inactivate platelet-activating factor (PAF). | −9.92813 | Wu et al. (2006) [55] |
PDIA2+ | Helps to load antigenic peptides into MHC I molecules and is therefore important in antigen recognition and clearing. | −4.4116 | LeBrasseur (2006) [56] |
BT.36112+ | (KIR) Killer cell immunoglobulin receptor suppresses the cytotoxic activity of NK cells. | −2.92833 | Vilches et al. (2002) [57] |
MGC137099+ | Is preferentially expressed on Th2 cells and is together with SEMA4A a stimulatory molecule for T-cell activation. | −2.54481 | European bioinformatics institute (2015) [58] |
PRLR+ | Cytokine receptor and important in the JAK-STAT, JAK-RUSH, Ras-Raf-MAPK and PI-3 K pathways. | −2.47279 | Bouchard et al. (1999) [59], Lee et al. (1999) [60], Amaral et al. (2004) [61] |
LY6G6E+ | Possible role of Ly-6 family members in T-cell activation, differentiation and maturation (mouse studies) | −2.4165 | Mallya et al. (2006) [62] |
BTRAPPIN-5+ | Multifunctional host-defense peptide with anti-proteolytic, anti-inflammatory and anti-microbial activities. | −2.25014 | Kato et al. (2010) [63] |
SUSD2+ | Contributes to evasion of immune responses by induction of apoptosis in activated T-cells | −2.24943 | Watson. (2011) [23] |
KLRJ1+ | (see Table 3 on RAJ) | −2.04608 | Storset et al. (2003) [27] |
FCRLA− | Leading to inflammatory responses and antibody-mediated cellular cytotoxicity. | 7.21319 | Inozume et al. (2007) [64] |
CXCL13− | Chemokine B-lymphocyte chemoattractant. | 6.63854 | Legler et al. (1998) [65] |
DEFB5− | Bovine neutrophil β-defensins exert broad spectrum of antimicrobial activities against several species that cause mastitis as S. aureus, E. coli, K. pneumoniae and P. aeruginosa | 6.0118 | Alnakip et al. (2014) [66] |
BT.53744− | Development and differentiation of B-cells into plasma cells. | 6.01462 | International Molecular Exchange Consortium (2015) [67] |
TNFRSF13C− | Mature B-cell survival. | 5.9961 | Thompson et al. (2001) [68] |
CD79B− | Initiation of the signal transduction cascade activated by the B-cell antigen receptor complex which will lead to antigen presentation. | 5.81055 | Luisiri et al. (1996) [69], Tseng et al. (1997) [70], Pelanda et al. (2002) [71] |
SRCRB4D− | Regulation of innate and adaptive immune responses. | 5.45381 | OMIM database (2004) [72] |
CD180− | Controls B-cell recognition and signaling of LPS. | 4.59918 | NCBI Reference Sequence Database (2008) [73] |
FCRL1− | Functions in B-cell activation and differentiation. | 4.43127 | |
CLEC4E− | Induces secretion of inflammatory cytokines after binding of ligands (such as damaged cells, funghi and microbacteria). | 4.4039 | Miyake et al. (2010) [76] |
CXCR5− | Chemokine plays an essential role in B-cell migration. | 4.00308 | Sáez de Guinoa et al. (2011) [25] |
CD19− | Acts as a B-cell coreceptor in conjunction with CD21 and CD81. | 3.8374 | Van Zelm et al. (2006) [77] |
P2RY8− | Regulator of the immune response. | 4.05228 | Amisten et al. (2007) [78] |
LTA− | Mediates a large variety of inflammatory, immunostimulatory and antiviral responses. | 3.70982 | NCBI Reference Sequence Database (2012) [79] |
CXCR4− | Receptor for SDF-1, has potent chemotactic activity for lymphocytes. | 3.67364 | Tamamis et al. (2014) [80] |
TLR10− | Role in pathogen recognition and activation of innate immunity. | 3.64532 | Lee et al. (2014) [81] |
SPP1− | Chemotactic for many cell types including macrophages, dendritic cells and T cells; it enhances B lymphocyte immunoglobulin production and proliferation. In inflammatory situations it stimulates both pro- and anti-inflammatory processes. | 3.49813 | Wang et al. (2008) [82] |
BANK1− | Is expressed during development of B-lineage cells. | 3.34384 | Dymecki et al. (1992) [83] |
FCRL3− | Regulator of the immune system. | 3.32282 | Swainson et al. (2010) [84] |
LTB− | LTs are important for innate and adaptive immune responses by controlling the expression of several adhesion molecules, other cytokines and chemokines | 2.50217 | Creus et al. (2012) [85] |
DOK3− | Negative regulator of JNK signaling in B-cells. | 3.02771 | Robson et al. (2004) [86] |
KLRF1− | Activating lectin-like receptor expressed on NK-cells and stimulates their cytotoxicity and cytokine release. | 3.00125 | Kuttruff et al. (2009) [31] |
FCER2− | Transportation in antibody feedback regulation | 2.85172 | Kijimoto-Ochiai (2002) [87] |
FCAMR− | is expressed constitutively on the majority of B-lymphocytes and macrophages; FCAMR functions as a receptor for the Fc fragment of IgA and IgM and binds IgA and IgM with high affinity and mediates their endocytosis | 2.82211 | |
CCL19− | Antimicrobial gene; may play a role in normal lymphocyte recirculation and homing. It also plays an important role in trafficking of T cells in thymus, and in T cell and B cell migration to secondary lymphoid organs | 2.54095 | National Center for Biotechnology Information Gene (2014) [90] |
TNFSF8− | Involved in cell differentiation, apoptosis and immune response | 2.43376 | Wei et al. (2011) [91] |
SOCS1− | Negative regulator of cytokine signaling. | 2.33913 | Krebs et al. (2011) [92] |
TIMD4− | Enhances the engulfment of apoptotic cells: involved in regulating T-cell proliferation and lymphotoxin signaling. | 2.304 | Uniprot (2015) [93] |
SIT1− | Negatively regulates T-cell receptor mediated signaling in T-cells. | 2.28439 | Marie-Cardine et al. (1999) [94] |
BDKRB1− | Receptor binding leads to increase in the cytosolic calcium ion concentration, resulting in chronic and acute inflammatory responses. | 2.26204 | |
AKAP5− | Is expressed in T-lymphocytes and may function to inhibit IL-2; IL-2 is part of the body’s natural responses to microbial infections. | 2.20946 | Schillace et al. (2002) [97] |
PGLYRP2− | Recognizes peptidoglycan, a component of bacterial cell walls. | 2.19916 | Dziarski et al. (2010) [98] |
CD37− | T-cell and B-cell interactions. | 2.13192 | Knobeloch et al. (2000) [99] |